| Shareholder | |||
|---|---|---|---|
| YUAN Fuer | 71.72% | 321.58M | |
| Cheung Ching HoNon-Executive Director | 41.63% | 906.49M | |
| chen hui | 7.97% | 35.74M | |
| Li Baoshan | 7.57% | 135.44M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| 關文焯 | 0 | -- | Rights not taken up | 66.08M | 3.91% | ||
| Li Baoshan | 41.50M | 0.07 | Rights not taken up | 135.44M | 7.57% | ||
| China Regenerative Medicine Tissue Engineering Limited | 65.02M | -- | Other event | 906.49M | 41.63% | ||
| Osibao Cosmetics International Limited | 65.02M | -- | Other event | 906.49M | 41.63% | ||
| Osibao Cosmetics Holding Limited | 65.02M | -- | Other event | 906.49M | 41.63% | ||
| China Regenerative Medicine Tissue Engineering Limited | 172.96M | 0.07 | Other event | 841.47M | 39.84% | ||
| Osibao Cosmetics International Limited | 172.96M | 0.07 | Other event | 841.47M | 39.84% | ||
| Osibao Cosmetics Holding Limited | 172.96M | 0.07 | Other event | 841.47M | 39.84% | ||
| Cheung Ching HoNon-Executive Director | 322.58M | 0.15 | Derivatives acquired | 668.51M | 44.11% | ||
| China Regenerative Medicine Tissue Engineering Limited | 322.58M | 0.15 | Derivatives acquired | 668.51M | 44.11% | ||
| Osibao Cosmetics International Limited | 322.58M | 0.15 | Derivatives acquired | 668.51M | 44.11% | ||
| Osibao Cosmetics Holding Limited | 322.58M | 0.15 | Derivatives acquired | 668.51M | 44.11% |
This page shows the major shareholders of BIOSYSEN (01355) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

